<DOC>
	<DOCNO>NCT00561639</DOCNO>
	<brief_summary>A SpetiFast multiplex PCR kit recently place market witch evidence DNA 90 % micro-organisms ( bacteria fungus ) implicate sepsis . However , clinical impact able detect DNA various agent unknown . We propose assess benefit patient care SeptiFast multiple PCR answer three question : 1/in patient septic immunosuppression , kit evidence etiologic agent reveal classical method ? 2/Does use PCR result permit different diagnostic hypothesis consider ? 3/Does SeptiFast result entail change therapeutic plan ?</brief_summary>
	<brief_title>Benefit SeptiFast Multiplex PCR Etiologic Diagnosis Therapeutic Approach Onco-hematology Patients Presenting Sepsis</brief_title>
	<detailed_description>This study double purpose : 1 . To compare result obtain SeptiFast system result classical microbiological sampling , particular hemoculture , immunosuppressed patient present sepsis . 2 . To perform blind assessment benefit septiFast care patient .</detailed_description>
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Toxemia</mesh_term>
	<mesh_term>Hematologic Diseases</mesh_term>
	<criteria>All patient oncohematologic cancerous pathology , hematologic disease chemotherapy and/or radiotherapy and/or immunosuppressant treatment progress present infection require hospitalisation meeting follow criterion : Sepsis ( least one follow sign ) : Fever &gt; 38.2°C hypothermia &lt; 36°C FO120 min PA &lt; 120 mmHg ( 50 mmHg reduction base number ) Respiratory F &gt; 30/min Confusion Hyperleucocytosis ( &gt; 12 G/l ) leucopenia ( &lt; 4 G/l ) CReactive protein &gt; 40 With without organ dysfunction define : Hypoxia ( PaO2/FiO2 &lt; 300mmHg ) Oliguria ( urine deficiency &lt; 0.5 ml/kg/h probe patient ) Creatinine &gt; 200umol/l INR &gt; 1.5 TCA &gt; 2 X control absence anticoagulant treatment Platelets &lt; 100 G/l Bilirubin &gt; 35 umol/l Lactatemia &gt; 2 mmol/l Arterial hypotension ( PAS &lt; 90mmHg , PAM &lt; 70mmHg reduction 40 mmHG know hypertension ) Minor patient Pregnancy A patient include within 15 day his/her precede inclusion</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>sepsis</keyword>
	<keyword>immunosuppressed</keyword>
	<keyword>multiplex PCR</keyword>
	<keyword>diagnosis</keyword>
	<keyword>therapeutic</keyword>
</DOC>